What is Fusion Diagnostics?
Established in 2010 and headquartered in Cedar Knolls, NJ, Fusion Diagnostics Laboratories provides a broad spectrum of clinical laboratory testing services. The company caters to healthcare providers, physicians, hospitals, and research facilities, offering in-house diagnostic solutions that encompass toxicology, genetics, virology, and COVID-19 testing. Serving a wide geographical area across New Jersey and extending into parts of New York and Pennsylvania, Fusion Diagnostics is dedicated to accessibility, offering discounted rates for uninsured patients. Their commitment to delivering timely and accurate results is supported by round-the-clock expert client service.
How much funding has Fusion Diagnostics raised?
Fusion Diagnostics has raised a total of $440K across 2 funding rounds:
Debt
$150K
Debt
$290K
Debt (2020): $150K with participation from PPP
Debt (2021): $290K led by PPP
Key Investors in Fusion Diagnostics
PPP
Public-Private Partnership
PPP
Public-Private Partnership
What's next for Fusion Diagnostics?
The substantial capital infusion, particularly the recent strategic investment, indicates Fusion Diagnostics is poised for significant scaling and potentially expanding its service offerings or geographical reach. Given the 'large-scale late-stage funding' context, the company is likely focusing on solidifying its market position, enhancing technological capabilities, and potentially pursuing strategic partnerships or acquisitions to further its competitive advantage in the diagnostic testing landscape.
See full Fusion Diagnostics company page
